Ajo LP Increased By $4.29 Million Its Amag Pharmaceuticals (AMAG) Stake; Tesaro (TSRO) Has 1.19 Sentiment

August 9, 2017 - By Marguerite Chambers

TESARO, Inc. is an oncology-focused biopharmaceutical company. The company has market cap of $6.20 billion. The Firm operates through the business of developing and commercializing of oncology-focused therapeutics segment. It currently has negative earnings. It is developing oncology-related product candidates, including rolapitant, niraparib and the product candidates under its immuno-oncology platform.

Ajo Lp increased Amag Pharmaceuticals (AMAG) stake by 138.27% reported in 2016Q4 SEC filing. Ajo Lp acquired 126,177 shares as Amag Pharmaceuticals (AMAG)’s stock declined 21.74%. The Ajo Lp holds 217,428 shares with $7.57 million value, up from 91,251 last quarter. Amag Pharmaceuticals now has $642.25M valuation. The stock declined 1.89% or $0.35 reaching $18.2 on the news. About 209,118 shares traded. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) has risen 3.00% since August 9, 2016 and is uptrending. It has underperformed by 13.70% the S&P500.

About 1.39 million shares traded or 36.27% up from the average. TESARO Inc (TSRO) has risen 254.28% since August 9, 2016 and is uptrending. It has outperformed by 237.58% the S&P500.

Nea Management Company Llc holds 54.94% of its portfolio in TESARO Inc for 10.28 million shares. Oracle Investment Management Inc owns 1.25 million shares or 27.84% of their US portfolio. Moreover, Blue Jay Capital Management Llc has 7.28% invested in the company for 89,695 shares. The New York-based Perceptive Advisors Llc has invested 6.58% in the stock. Venbio Select Advisor Llc, a California-based fund reported 231,700 shares.

Since January 1, 0001, it had 0 insider purchases, and 10 sales for $4.89 million activity.

Ratings analysis reveals 55% of Tesaro’s analysts are positive. Out of 11 Wall Street analysts rating Tesaro, 6 give it “Buy”, 0 “Sell” rating, while 5 recommend “Hold”. The lowest target is $97.0 while the high is $182.0. The stock’s average target of $141.50 is 22.99% above today’s ($115.05) share price. TSRO was included in 11 notes of analysts from August 30, 2016. The stock of TESARO Inc (NASDAQ:TSRO) has “Outperform” rating given on Monday, October 10 by FBR Capital. Wedbush maintained the stock with “Outperform” rating in Monday, October 10 report. The company was initiated on Friday, January 13 by Morgan Stanley. On Monday, April 10 the stock rating was initiated by Janney Capital with “Neutral”. The firm has “Outperform” rating given on Monday, October 10 by RBC Capital Markets. The company was downgraded on Friday, November 4 by Raymond James. The rating was downgraded by Robert W. Baird to “Neutral” on Monday, February 27. The stock has “Neutral” rating by Bank of America on Tuesday, August 30. The firm has “Overweight” rating by Piper Jaffray given on Wednesday, April 12. On Friday, February 10 the stock rating was downgraded by Leerink Swann to “Mkt Perform”.

Among 9 analysts covering AMAG Pharmaceuticals (NASDAQ:AMAG), 2 have Buy rating, 1 Sell and 6 Hold. Therefore 22% are positive. AMAG Pharmaceuticals had 26 analyst reports since August 18, 2015 according to SRatingsIntel. Needham initiated AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) rating on Thursday, October 27. Needham has “Buy” rating and $40 target. The stock of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) has “Hold” rating given on Wednesday, January 11 by Needham. The stock of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) has “Hold” rating given on Thursday, November 19 by Deutsche Bank. The rating was maintained by Cantor Fitzgerald on Monday, June 26 with “Hold”. The company was downgraded on Friday, February 3 by Cowen & Co. On Wednesday, May 4 the stock rating was maintained by Leerink Swann with “Outperform”. On Tuesday, January 10 the stock rating was downgraded by Leerink Swann to “Mkt Perform”. Deutsche Bank maintained the stock with “Hold” rating in Wednesday, November 4 report. As per Wednesday, August 19, the company rating was downgraded by Zacks. Jefferies initiated AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) rating on Tuesday, August 18. Jefferies has “Buy” rating and $80 target.

Investors sentiment increased to 1.52 in 2016 Q4. Its up 0.45, from 1.07 in 2016Q3. It improved, as 20 investors sold AMAG shares while 53 reduced holdings. 47 funds opened positions while 64 raised stakes. 39.82 million shares or 1.19% less from 40.30 million shares in 2016Q3 were reported. Buckhead Capital Mngmt Ltd Liability Co owns 16,345 shares. Cubist Systematic Strategies Ltd accumulated 6,928 shares. Exane Derivatives holds 0% of its portfolio in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) for 19,392 shares. Great West Life Assurance Can owns 45,022 shares. Pnc Fincl Serv Grp Inc invested in 0% or 7,521 shares. Louisiana State Employees Retirement Systems stated it has 13,800 shares. 24 are held by Piedmont Inv Advsrs Ltd Limited Liability Company. First Tru Ltd Partnership stated it has 36,828 shares. Tfs Capital Ltd reported 47,214 shares or 0.44% of all its holdings. Blackrock holds 0% of its portfolio in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) for 7,358 shares. Omers Administration holds 0.01% or 15,600 shares in its portfolio. Panagora Asset Mngmt Inc has 0% invested in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Nomura Holdg stated it has 53,424 shares. Convergence Investment Prtn Limited Company holds 0.16% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) or 32,770 shares. Bancshares Of America Corporation De stated it has 0% of its portfolio in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG).

Ajo Lp decreased Johnson & Johnson (NYSE:JNJ) stake by 58,926 shares to 6.29 million valued at $724.48 million in 2016Q4. It also reduced Dr Pepper Snapple Grp (NYSE:DPS) stake by 412,134 shares and now owns 1.07 million shares. Teradata Corp (NYSE:TDC) was reduced too.